{"database": "openregs", "table": "documents", "is_view": false, "human_description_en": "where agency_id = \"FDA\", docket_id = \"FDA-1978-N-0023\" and posted_year = 2008 sorted by posted_date descending", "rows": [["FDA-1978-N-0023-0081", "FDA", "FDA-1978-N-0023", "Answer from FDA/CDER to Joan A. Kuriansky ,Older Women's League", "Other", "Answer", "2008-10-06T04:00:00Z", 2008, 10, "2008-10-06T04:00:00Z", "1979-02-02T04:59:59Z", "2019-11-01T20:17:14Z", null, 0, 0, "090000648055f147"], ["FDA-1978-N-0023-0047", "FDA", "FDA-1978-N-0023", "Letter from FDA/CDER to Dr. John Kennedy, Jr.", "Other", "Letter(s)", "2008-10-03T04:00:00Z", 2008, 10, "2008-10-03T04:00:00Z", null, "2019-09-25T19:34:22Z", null, 0, 0, "090000648055f1b8"], ["FDA-1978-N-0023-0043", "FDA", "FDA-1978-N-0023", "Correction Letter from Hunter, Maclean, Exley & Dunn, P.C. On Behalf Of Carson Products Company to FDA DDM", "Other", "Correction(s)", "2008-10-03T04:00:00Z", 2008, 10, "2008-10-03T04:00:00Z", null, "2019-09-30T13:12:32Z", null, 0, 0, "090000648055f024"], ["FDA-1978-N-0023-0060", "FDA", "FDA-1978-N-0023", "Tab Reference 1: Kari, F. W., \"NTP Technical Report of the Toxicology and Carcinogenesis Studies of Hydroquinone in F344/N Rats and B6C3F1 Mice (Gavage Studies),\" NTP TR366, NTP Publication No. 89-2821, 1989. (Page 101-200) re: Internal Memorandum from Susan S. Johnson, Acting Director Division of Nonprescription Regulation Development Office of Nonprescription Products to Division of Dockets", "Supporting & Related Material", "Background Material", "2008-10-03T04:00:00Z", 2008, 10, null, null, "2019-10-02T17:48:55Z", null, 0, 0, "090000648055f20c"], ["FDA-1978-N-0023-0046", "FDA", "FDA-1978-N-0023", "Letter from FDA/CDER to University of Pennsylvania", "Other", "Letter(s)", "2008-10-03T04:00:00Z", 2008, 10, "2008-10-03T04:00:00Z", null, "2019-09-25T19:28:44Z", null, 0, 0, "090000648055f1b4"], ["FDA-1978-N-0023-0039", "FDA", "FDA-1978-N-0023", "Enclosure 2: Salient Observations from the Published Literature on Exogenous Ochronosis Reportedly Associated with Skin Discoloration Fade Products re: Letter from the Nonprescription Drug Manufacturers Association to FDA/CDER", "Supporting & Related Material", "Background Material", "2008-10-03T04:00:00Z", 2008, 10, "2008-10-03T04:00:00Z", null, "2019-09-27T17:26:10Z", null, 0, 0, "090000648055f0b2"], ["FDA-1978-N-0023-0031", "FDA", "FDA-1978-N-0023", "Request For Extension From Rogers Hoge & Hills On Behalf Of Browne Drug Co., Inc.", "Other", "Request for Extension", "2008-10-03T04:00:00Z", 2008, 10, "2008-10-03T04:00:00Z", "1979-02-02T04:59:59Z", "2019-09-24T13:20:48Z", null, 0, 0, "090000648055eff9"], ["FDA-1978-N-0023-0057", "FDA", "FDA-1978-N-0023", "Tab Reference 1: Kari, F. W., \"NTP Technical Report of the Toxicology and Carcinogenesis Studies of Hydroquinone in F344/N Rats and B6C3F1 Mice (Gavage Studies),\" NTP TR366, NTP Publication No. 89-2821, 1989. (Page 1-100) re: Internal Memorandum from Susan S. Johnson, Acting Director Division of Nonprescription Regulation Development Office of Nonprescription Products to Division of Dockets", "Supporting & Related Material", "Background Material", "2008-10-03T04:00:00Z", 2008, 10, null, null, "2019-10-02T17:49:27Z", null, 0, 0, "090000648055f1ec"], ["FDA-1978-N-0023-0040", "FDA", "FDA-1978-N-0023", "Enclosure 1: Chronic Health Effects Testing for Hydroquinone re: Letter from the Nonprescription Drug Manufacturers Association to FDA/CDER", "Supporting & Related Material", "Background Material", "2008-10-03T04:00:00Z", 2008, 10, "2008-10-03T04:00:00Z", null, "2019-09-27T17:25:50Z", null, 0, 0, "090000648055f0c4"], ["FDA-1978-N-0023-0050", "FDA", "FDA-1978-N-0023", "Letter from FDA/CDER to National Medical Association", "Other", "Letter(s)", "2008-10-03T04:00:00Z", 2008, 10, "2008-10-03T04:00:00Z", null, "2019-09-25T19:57:30Z", null, 0, 0, "090000648055f1c3"], ["FDA-1978-N-0023-0030", "FDA", "FDA-1978-N-0023", "Report from the National Toxicology Program, Toxicology and Carcinogenesis Studies of Hydroquinone (CAS No. 123-31-9) in F344/N Rats and B6C3F Mice (Gavage Studies)", "Other", "Report", "2008-10-03T04:00:00Z", 2008, 10, "2008-10-03T04:00:00Z", null, "2019-10-29T14:53:24Z", null, 0, 0, "090000648055f02b"], ["FDA-1978-N-0023-0035", "FDA", "FDA-1978-N-0023", "A Report By The City of New York Department of Consumer Affairs; A Study In Hype And Risk: The Marketing Of Skin Bleaches", "Other", "Report", "2008-10-03T04:00:00Z", 2008, 10, "2008-10-03T04:00:00Z", null, "2019-09-30T13:03:09Z", null, 0, 0, "090000648055f070"], ["FDA-1978-N-0023-0054", "FDA", "FDA-1978-N-0023", "Ref. 1: Memorandum of Meeting between FDA CDER, NDMA and Carcinogenicity Assessment Committee", "Other", "Memorandum", "2008-10-03T04:00:00Z", 2008, 10, "2008-10-03T04:00:00Z", null, "2019-10-10T18:59:54Z", null, 0, 0, "090000648055f1d3"], ["FDA-1978-N-0023-0053", "FDA", "FDA-1978-N-0023", "Memorandum of Meeting between Nonprescription Drug Manufacturers Association et. al. and FDA", "Other", "Memorandum", "2008-10-03T04:00:00Z", 2008, 10, "2008-10-03T04:00:00Z", null, "2019-09-26T12:01:08Z", null, 0, 0, "090000648055f1d0"], ["FDA-1978-N-0023-0058", "FDA", "FDA-1978-N-0023", "Tab Reference 6: Bio/dynamics Inc., \"A Developmental Toxicity Study in Rabbits With Hydroquinone,\" Project No. 87-3Z20, 1989, in OTC Vol. 16ATFM2. re: Internal Memorandum from Susan S. Johnson, Acting Director Division of Nonprescription Regulation Development Office of Nonprescription Products to Division of Dockets Management (HFA-350) August 17 2006", "Supporting & Related Material", "Background Material", "2008-10-03T04:00:00Z", 2008, 10, null, null, "2019-10-02T17:48:18Z", null, 0, 0, "090000648055f206"], ["FDA-1978-N-0023-0052", "FDA", "FDA-1978-N-0023", "Letter from FDA/CDER to Lilly A. Jackson", "Other", "Letter(s)", "2008-10-03T04:00:00Z", 2008, 10, "2008-10-03T04:00:00Z", null, "2019-09-26T11:48:24Z", null, 0, 0, "090000648055f1cc"], ["FDA-1978-N-0023-0037", "FDA", "FDA-1978-N-0023", "Letter From FDA/CDER to Nonprescription Drug Manufacturers Association", "Other", "Letter(s)", "2008-10-03T04:00:00Z", 2008, 10, "2008-10-03T04:00:00Z", null, "2019-09-26T16:44:48Z", null, 0, 0, "090000648055f099"], ["FDA-1978-N-0023-0041", "FDA", "FDA-1978-N-0023", "Letter from the Nonprescription Drug Manufacturers Association to FDA/CDER", "Other", "Letter(s)", "2008-10-03T04:00:00Z", 2008, 10, "2008-10-03T04:00:00Z", null, "2019-09-27T17:24:43Z", null, 0, 0, "090000648055f0ed"], ["FDA-1978-N-0023-0051", "FDA", "FDA-1978-N-0023", "Letter from FDA/CDER to King-Drew Medical Center", "Other", "Letter(s)", "2008-10-03T04:00:00Z", 2008, 10, "2008-10-03T04:00:00Z", null, "2019-09-26T11:45:27Z", null, 0, 0, "090000648055f1c8"], ["FDA-1978-N-0023-0048", "FDA", "FDA-1978-N-0023", "Letter from FDA/CDER to Dr. Harold Minus", "Other", "Letter(s)", "2008-10-03T04:00:00Z", 2008, 10, "2008-10-03T04:00:00Z", null, "2019-09-25T19:39:09Z", null, 0, 0, "090000648055f1bb"], ["FDA-1978-N-0023-0044", "FDA", "FDA-1978-N-0023", "Letter From Nonprescription Drug Manufacturers Association to FDA/CDER", "Other", "Letter(s)", "2008-10-03T04:00:00Z", 2008, 10, "2008-10-03T04:00:00Z", null, "2019-09-27T18:08:12Z", null, 0, 0, "090000648055f149"], ["FDA-1978-N-0023-0055", "FDA", "FDA-1978-N-0023", "Letter from FDA/CDER to Nonprescription Drug Manufacturers Association", "Other", "Letter(s)", "2008-10-03T04:00:00Z", 2008, 10, "2008-10-03T04:00:00Z", null, "2019-09-26T12:34:55Z", null, 0, 0, "090000648055f1d6"], ["FDA-1978-N-0023-0045", "FDA", "FDA-1978-N-0023", "Report from Nonprescription Drug Manufacturers Association", "Other", "Report", "2008-10-03T04:00:00Z", 2008, 10, "2008-10-03T04:00:00Z", null, "2019-09-25T19:10:40Z", null, 0, 0, "090000648055f14b"], ["FDA-1978-N-0023-0056", "FDA", "FDA-1978-N-0023", "Tab Reference 1: Kari, F. W., \"NTP Technical Report of the Toxicology and Carcinogenesis Studies of Hydroquinone in F344/N Rats and B6C3F1 Mice (Gavage Studies),\" NTP TR366, NTP Publication No. 89-2821, 1989. (Page 201-253) re: Internal Memorandum from Susan S. Johnson, Acting Director Division of Nonprescription Regulation Development Office of Nonprescription Products to Division of Dockets", "Supporting & Related Material", "Background Material", "2008-10-03T04:00:00Z", 2008, 10, null, null, "2019-10-02T17:49:41Z", null, 0, 0, "090000648055f1e3"], ["FDA-1978-N-0023-0029", "FDA", "FDA-1978-N-0023", "Reference List From The Proprietary Association", "Other", "Background Material", "2008-10-03T04:00:00Z", 2008, 10, "2008-10-03T04:00:00Z", null, "2019-09-30T13:27:15Z", null, 0, 0, "090000648055f020"], ["FDA-1978-N-0023-0033", "FDA", "FDA-1978-N-0023", "Letter From Nonprescription Drug Manufacturers Association to FDA/CDER", "Other", "Letter(s)", "2008-10-03T04:00:00Z", 2008, 10, "2008-10-03T04:00:00Z", null, "2019-09-30T13:06:41Z", null, 0, 0, "090000648055f06b"], ["FDA-1978-N-0023-0034", "FDA", "FDA-1978-N-0023", "Letter From Nonprescription Drug Manufacturers Association to FDA/Office of the Commissioner", "Other", "Letter(s)", "2008-10-03T04:00:00Z", 2008, 10, "2008-10-03T04:00:00Z", null, "2019-09-30T13:04:47Z", null, 0, 0, "090000648055f06d"], ["FDA-1978-N-0023-0038", "FDA", "FDA-1978-N-0023", "Letter From Nonprescription Drug Manufacturers Association to FDA CDER", "Other", "Letter(s)", "2008-10-03T04:00:00Z", 2008, 10, "2008-10-03T04:00:00Z", null, "2019-09-30T12:42:04Z", null, 0, 0, "090000648055f0b0"], ["FDA-1978-N-0023-0042", "FDA", "FDA-1978-N-0023", "Memorandum Of Meeting Between FDA/CDER And Nonprescription Drug Manufacturers Association Hydroquinone Task Force Representatives", "Other", "Memorandum", "2008-10-03T04:00:00Z", 2008, 10, "2008-10-03T04:00:00Z", null, "2019-09-30T12:35:15Z", null, 0, 0, "090000648055f127"], ["FDA-1978-N-0023-0049", "FDA", "FDA-1978-N-0023", "Letter from FDA/CDER to Dr. Rebat Halder", "Other", "Letter(s)", "2008-10-03T04:00:00Z", 2008, 10, "2008-10-03T04:00:00Z", null, "2019-09-25T19:54:27Z", null, 0, 0, "090000648055f1bf"], ["FDA-1978-N-0023-0032", "FDA", "FDA-1978-N-0023", "Letter From New York City Department of Consumer Affairs to FDA", "Other", "Letter(s)", "2008-10-03T04:00:00Z", 2008, 10, "2008-10-03T04:00:00Z", null, "2019-09-30T13:09:08Z", null, 0, 0, "090000648055f065"], ["FDA-1978-N-0023-0036", "FDA", "FDA-1978-N-0023", "Letter From FDA/CDER to New York City Department of Consumer Affairs", "Other", "Letter(s)", "2008-10-03T04:00:00Z", 2008, 10, "2008-10-03T04:00:00Z", null, "2019-09-27T18:46:56Z", null, 0, 0, "090000648055f076"], ["FDA-1978-N-0023-0059", "FDA", "FDA-1978-N-0023", "Internal Memorandum from Susan S. Johnson, Acting Director Division of Nonprescription Regulation Development Office of Nonprescription Products to Division of Dockets Management (HFA-350) August 17 2006", "Supporting & Related Material", "Background Material", "2008-10-03T04:00:00Z", 2008, 10, null, null, "2019-09-11T19:06:13Z", null, 0, 0, "090000648055f208"]], "truncated": false, "filtered_table_rows_count": 33, "expanded_columns": [], "expandable_columns": [[{"column": "docket_id", "other_table": "dockets", "other_column": "id"}, "title"]], "columns": ["id", "agency_id", "docket_id", "title", "document_type", "subtype", "posted_date", "posted_year", "posted_month", "comment_start_date", "comment_end_date", "last_modified", "fr_doc_num", "open_for_comment", "withdrawn", "object_id"], "primary_keys": ["id"], "units": {}, "query": {"sql": "select id, agency_id, docket_id, title, document_type, subtype, posted_date, posted_year, posted_month, comment_start_date, comment_end_date, last_modified, fr_doc_num, open_for_comment, withdrawn, object_id from documents where \"agency_id\" = :p0 and \"docket_id\" = :p1 and \"posted_year\" = :p2 order by posted_date desc limit 101", "params": {"p0": "FDA", "p1": "FDA-1978-N-0023", "p2": "2008"}}, "facet_results": {"agency_id": {"name": "agency_id", "type": "column", "hideable": false, "toggle_url": "/openregs/documents.json?agency_id=FDA&docket_id=FDA-1978-N-0023&posted_year=2008", "results": [{"value": "FDA", "label": "FDA", "count": 33, "toggle_url": "https://regs.datadawn.org/openregs/documents.json?docket_id=FDA-1978-N-0023&posted_year=2008", "selected": true}], "truncated": false}, "document_type": {"name": "document_type", "type": "column", "hideable": false, "toggle_url": "/openregs/documents.json?agency_id=FDA&docket_id=FDA-1978-N-0023&posted_year=2008", "results": [{"value": "Other", "label": "Other", "count": 26, "toggle_url": "https://regs.datadawn.org/openregs/documents.json?agency_id=FDA&docket_id=FDA-1978-N-0023&posted_year=2008&document_type=Other", "selected": false}, {"value": "Supporting & Related Material", "label": "Supporting & Related Material", "count": 7, "toggle_url": "https://regs.datadawn.org/openregs/documents.json?agency_id=FDA&docket_id=FDA-1978-N-0023&posted_year=2008&document_type=Supporting+%26+Related+Material", "selected": false}], "truncated": false}, "posted_year": {"name": "posted_year", "type": "column", "hideable": false, "toggle_url": "/openregs/documents.json?agency_id=FDA&docket_id=FDA-1978-N-0023&posted_year=2008", "results": [{"value": 2008, "label": 2008, "count": 33, "toggle_url": "https://regs.datadawn.org/openregs/documents.json?agency_id=FDA&docket_id=FDA-1978-N-0023", "selected": true}], "truncated": false}}, "suggested_facets": [{"name": "subtype", "toggle_url": "https://regs.datadawn.org/openregs/documents.json?agency_id=FDA&docket_id=FDA-1978-N-0023&posted_year=2008&_facet=subtype"}, {"name": "posted_date", "toggle_url": "https://regs.datadawn.org/openregs/documents.json?agency_id=FDA&docket_id=FDA-1978-N-0023&posted_year=2008&_facet=posted_date"}, {"name": "comment_start_date", "toggle_url": "https://regs.datadawn.org/openregs/documents.json?agency_id=FDA&docket_id=FDA-1978-N-0023&posted_year=2008&_facet=comment_start_date"}, {"name": "posted_date", "type": "date", "toggle_url": "https://regs.datadawn.org/openregs/documents.json?agency_id=FDA&docket_id=FDA-1978-N-0023&posted_year=2008&_facet_date=posted_date"}, {"name": "comment_start_date", "type": "date", "toggle_url": "https://regs.datadawn.org/openregs/documents.json?agency_id=FDA&docket_id=FDA-1978-N-0023&posted_year=2008&_facet_date=comment_start_date"}, {"name": "comment_end_date", "type": "date", "toggle_url": "https://regs.datadawn.org/openregs/documents.json?agency_id=FDA&docket_id=FDA-1978-N-0023&posted_year=2008&_facet_date=comment_end_date"}, {"name": "last_modified", "type": "date", "toggle_url": "https://regs.datadawn.org/openregs/documents.json?agency_id=FDA&docket_id=FDA-1978-N-0023&posted_year=2008&_facet_date=last_modified"}], "next": null, "next_url": null, "private": false, "allow_execute_sql": true, "query_ms": 447.38448702264577, "source": "Federal Register API & Regulations.gov API", "source_url": "https://www.federalregister.gov/developers/api/v1", "license": "Public Domain (U.S. Government data)", "license_url": "https://www.regulations.gov/faq"}